Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

计划入组 90 人 · 首次发布于 2026 年 9 月 3 日

EFFECT OF AEROBIC TRAINING VERSUS MYOFACIAL RELEASE ON CLAUDICATION AMONG PREPHERAIL ARTERAIL INSUFFIECENCY PATIENTS

计划入组 40 人 · 首次发布于 2021 年 2 月 2 日

Plasmodium Falciparum Artemisinin Resistance Vietnam

计划入组 95 人 · 首次发布于 2013 年 1 月 25 日

Piperaquine Phosphate/Artenimol

CarThera

Chlamydia(Abera)

Artery Therapeutics, Inc.

United States

Artesa Labs, LLC

United States

CARTHERA

France

ArteraAI Prostate Test Expands Access with California Lab License

Diagnexia Partners with Artera to Launch AI-Powered Prostate Cancer Test in UK

Artera's AI Algorithm Identifies Which Prostate Cancer Patients Benefit from Intensive Therapy, Earning Best of ASCO Recognition